Mark Olfson, MD, MPH

Department of Psychiatry, Vagelos College of Physicians & Surgeons Columbia University and New York State Psychiatric Institute, New York, New York; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York

JCP
Commentary

March 5, 2019

Read expert commentary on guidelines for treatment-resistant schizophrenia (TRS) to make more informed treatment decisions.
John M. Kane, Ofer Agid, Marjorie L. Baldwin, et al
JCP
Original Research

October 9, 2018

Psychiatric disorders often co-occur, and comorbidity patterns as well as suicide risk vary across the lifespan. Read this article to learn if suicide attempt risk in older and younger...
Rachel Pascal de Raykeer, Nicolas Hoertel, Carlos Blanco, et al
JCP
Original Research

September 11, 2018

Insomnia has been linked to several medical conditions, but the relationship between insomnia and these conditions can be unclear. Read this article to learn more about the connection between...
Mark Olfson, Melanie Wall, Shang-Min Liu, et al
JCP
Original Research

July 31, 2018

Many individual factors influence risk of suicide attempt. How can these disparate factors be understood in light of each other? Read this article to learn about a comprehensive model...
Nicolas Hoertel, Carlos Blanco, Mark Olfson, et al
JCP
Letter to the Editor

October 25, 2017

Christoph U. Correll, Leslie Citrome, Peter M. Haddad, et al
JCP
Original Research

August 23, 2017

When children as young as 3 years old are prescribed anticonvulsants, antipsychotics, or psychotropic polypharmacy for their first diagnosis of ADHD, what is the trajectory of treatment in subsequent...
Almut G. Winterstein, Rene Soria-Saucedo, Tobias Gerhard, et al
JCP
Original Research

July 18, 2017

In 2015, the FDA removed WBC monitoring altogether and reduced the threshold for ANCs before interruption of clozapine treatment was required. The current study looks at almost 250 clozapine-treated...
Ryan S. Sultan, Mark Olfson, Christoph U. Correll, et al
JCP
Original Research

July 5, 2017

Antipsychotic medications are increasingly prescribed to treat depression. But is this use always warranted? Read the article by Gerhard and colleagues to learn how often antipsychotics are prescribed in...
Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, et al
JCP
Article

March 29, 2017

The increasing overlap of mood disorders and antipsychotic use in youth is a growing area of concern. This meta-analysis examined the current findings on the frequency of mood disorders...
Chiara Cervesi, Su Young Park, Britta Galling, et al
JCP
Original Research

January 25, 2017

If clinical trials by design exclude as many as 85% of individuals with a target disorder, how can these studies be representative of the clinical population? Discover in this...
Carlos Blanco, Aimee N. Campbell, Melanie M. Wall, et al
JCP
Original Research

December 28, 2016

Carlos Blanco, Melanie M. Wall, Martin A. Lindquist, et al
JCP
DELETE Evaluating the Evidence

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.
Christoph U. Correll, Leslie Citrome, Peter M. Haddad, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe